OSMITROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Osmitrol, and when can generic versions of Osmitrol launch?
Osmitrol is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in OSMITROL is mannitol. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the mannitol profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OSMITROL?
- What are the global sales for OSMITROL?
- What is Average Wholesale Price for OSMITROL?
Summary for OSMITROL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for OSMITROL |
| What excipients (inactive ingredients) are in OSMITROL? | OSMITROL excipients list |
| DailyMed Link: | OSMITROL at DailyMed |
US Patents and Regulatory Information for OSMITROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | OSMITROL 10% IN WATER | mannitol | INJECTABLE;INJECTION | 013684-002 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Baxter Hlthcare | OSMITROL 5% IN WATER | mannitol | INJECTABLE;INJECTION | 013684-001 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Baxter Hlthcare | OSMITROL 15% IN WATER IN PLASTIC CONTAINER | mannitol | INJECTABLE;INJECTION | 013684-008 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
